Roshawn A. Blunt is a director of Kronos Bio Inc.
Person profile
Roles
Kronos Bio
Director
Reneo Pharmaceuticals
Director
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kronos Bio, Inc.
26 Jun 23
4
Reneo Pharmaceuticals, Inc.
8 Jun 23
4
Reneo Pharmaceuticals, Inc.
2 Aug 22
3
Reneo Pharmaceuticals, Inc.
2 Aug 22
4
Kronos Bio, Inc.
29 Jun 22
4
Kronos Bio, Inc.
15 Nov 21
3
Kronos Bio, Inc.
15 Nov 21
4
Adamis Pharmaceuticals Corp
13 Feb 20
3
Adamis Pharmaceuticals Corp
10 Oct 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jun 23 | KRON Kronos Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 1.48 | 34,000 | 50.32 k | 34,000 |
6 Jun 23 | RPHM Reneo Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 9.01 | 14,815 | 133.48 k | 14,815 |